COVID-19 vaccines are undergoing a rigorous development process that includes tens of thousands of study participants to generate the needed non-clinical, clinical, and manufacturing data. FDA will undertake a comprehensive evaluation of this information submitted by a vaccine manufacturer. Post-authorization vaccine safety monitoring is a federal government responsibility shared https://russellq888kzo5.wikinewspaper.com/user